BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37330463)

  • 1. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.
    Wolfrum M; Handerer IJ; Moccetti F; Schmeisser A; Braun-Dullaeus RC; Toggweiler S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):306. PubMed ID: 37330463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
    Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Seeger J; Kapadia SR; Kodali S; Linke A; Wöhrle J; Haussig S; Makkar R; Mehran R; Rottbauer W; Leon M
    Eur Heart J; 2019 May; 40(17):1334-1340. PubMed ID: 30590554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Isogai T; Vanguru HR; Krishnaswamy A; Agrawal A; Spilias N; Shekhar S; Saad AM; Verma BR; Puri R; Reed GW; Popović ZB; Unai S; Yun JJ; Uchino K; Kapadia SR
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):810-820. PubMed ID: 35916117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
    Kapadia SR; Makkar R; Leon M; Abdel-Wahab M; Waggoner T; Massberg S; Rottbauer W; Horr S; Sondergaard L; Karha J; Gooley R; Satler L; Stoler RC; Messé SR; Baron SJ; Seeger J; Kodali S; Krishnaswamy A; Thourani VH; Harrington K; Pocock S; Modolo R; Allocco DJ; Meredith IT; Linke A;
    N Engl J Med; 2022 Oct; 387(14):1253-1263. PubMed ID: 36121045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
    Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
    Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis.
    Kaur A; Dhaliwal AS; Sohal S; Gwon Y; Gupta S; Bhatia K; Dominguez AC; Basman C; Tamis-Holland J
    J Am Heart Assoc; 2024 Feb; 13(3):e030587. PubMed ID: 38240252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Clinical Impact of Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kroon HG; van der Werf HW; Hoeks SE; van Gils L; van den Berge FR; El Faquir N; Rahhab Z; Daemen J; Poelman J; Schurer RAJ; van den Heuvel A; de Jaegere P; van der Harst P; Van Mieghem NM
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007605. PubMed ID: 31195822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Cerebral Embolic Protection for Bicuspid Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    Zhang J; Li X; Tian R; Zong M; Gu X; Xu F; Chen Y; Li C
    J Am Heart Assoc; 2023 Jun; 12(12):e028890. PubMed ID: 37301750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Cerebral Embolic Protection Devices in Transcatheter Procedures: A Systematic Review and Meta-Analysis.
    Baloch ZQ; Haider SJ; Siddiqui HF; Shaikh FN; Shah BUD; Ansari MM; Qintar M
    Curr Probl Cardiol; 2023 Jul; 48(7):101675. PubMed ID: 36870550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: a meta-analysis of in-hospital outcomes.
    Shimamura J; Kuno T; Malik A; Yokoyama Y; Gupta R; Ahmad H; Briasoulis A
    Cardiovasc Interv Ther; 2022 Jul; 37(3):549-557. PubMed ID: 34773568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: A clinical end-points meta-analysis.
    Mohananey D; Sankaramangalam K; Kumar A; Jobanputra Y; Villablanca P; Krishnaswamy A; Mick S; Svensson LG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):785-791. PubMed ID: 29550047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
    McGrath D; Salehi P; Weintraub A; Zhan Y
    J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials.
    Al-Abdouh A; Upadhrasta S; Fashanu O; Elias H; Zhao D; Hasan RK; Michos ED
    Cardiovasc Revasc Med; 2020 Apr; 21(4):461-466. PubMed ID: 31447314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study.
    Kawakami R; Gada H; Rinaldi MJ; Nazif TM; Leon MB; Kapadia S; Krishnaswamy A; Sakamoto A; Sato Y; Mori M; Kawai K; Cornelissen A; Park JE; Ghosh SKB; Abebe BG; Romero M; Virmani R; Finn AV
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e011358. PubMed ID: 35272475
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebral Embolic Protection and Stroke-Related Mortality Following Transcatheter Aortic Valve Replacement.
    Isogai T; Bansal A; Vanguru HR; Agrawal A; Shekhar S; Puri R; Reed GW; Krishnaswamy A; Uchino K; Kapadia SR
    JACC Cardiovasc Interv; 2022 Mar; 15(5):569-571. PubMed ID: 35272784
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use and Outcomes of Cerebral Protection Devices for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Clinical Practice.
    Stachon P; Kaier K; Heidt T; Wolf D; Duerschmied D; Staudacher D; Zehender M; Bode C; von Zur Mühlen C
    JACC Cardiovasc Interv; 2021 Jan; 14(2):161-168. PubMed ID: 33478631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.